Journal of vascular surgery. Venous and lymphatic disorders最新文献

英文中文

A new challenging dilemma to prevent major cardiovascular events in patients with chronic venous disorders 预防慢性静脉疾病患者重大心血管事件的新挑战

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102311

Paolo Zamboni MD

引用次数: 0

The indispensable role of disaster preparedness in venous thromboembolism prevention: Insights from Japan 备灾在静脉血栓栓塞预防中不可或缺的作用：来自日本的见解

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102313

Rashad A. Bishara RPVI, MS, FRCS

引用次数: 0

Full metal jacket coiling vs leave nothing behind gluing concept for treatment of pelvic venous disorders 治疗盆腔静脉疾病的全金属套盘绕与不留任何痕迹的胶合概念

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102321

Romaric Loffroy MD, PhD

引用次数: 0

Nonrotational mechano-chemical ablation with foam injection - another option for nonthermal nontumescent incompetent truncal vein treatment 泡沫注射非旋转机械化学消融-非热非肿胀的无能截静脉治疗的另一种选择

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102346

Tomasz Urbanek MD, PhD

引用次数: 0

Model for concomitant pulmonary embolism in a deep vein thrombosis patient 深静脉血栓患者并发肺栓塞模型

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102323

Saad Ahmad MBBS, Rayyan Ali MBBS

引用次数: 0

Information for Readers 读者资讯

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/S2213-333X(25)00206-9

引用次数: 0

Four key inflammatory pathways and targets in diabetic foot ulcers explored through data-driven analysis 通过数据驱动分析，探索糖尿病足溃疡的四个关键炎症途径和靶点

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102304

Jia-Yue Feng MSc, Shang Ju MSc

引用次数: 0

Reply to: Modeling concomitant pulmonary embolism in patients with deep vein thrombosis: Can we do better? 回复：深静脉血栓患者并发肺栓塞建模：我们能做得更好吗？

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102324

Maofeng Gong MD, Xu He MD, Jianping Gu MBBS

引用次数: 0

Disaster-associated venous thromboembolism countermeasures in Japan: Insights from past major earthquakes 日本与灾害相关的静脉血栓栓塞对策：来自过去大地震的见解。

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102312

Keisuke Kamada MD , Eri Fukaya MD, PhD , Eriko Iwata MD, PhD , Daiki Uchida MD, PhD , Makoto Mo MD, PhD , Kazuhiko Hanzawa MD, PhD , Shinsaku Ueda MD, PhD , Nobuyoshi Azuma MD, PhD

Japan experiences more than 1000 perceptible earthquakes annually, including major events such as the 2011 Great East Japan Earthquake and the 1995 Great Hanshin-Awaji Earthquake. These events lead to a documented increase in cardiovascular events, particularly venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis (DVT). Disaster-associated VTE is influenced by Virchow's triad: hemodynamic stasis, hypercoagulability, and endothelial injury. The incidence of DVT after earthquakes ranges from 10% to 30%, often developing 1 to 2 weeks post disaster. Early interventions in evacuation shelters to prevent venous stasis and hypercoagulability are critical. Left untreated, DVT can progress to pulmonary embolism, which may be fatal; however, most cases are preventable through timely intervention and improved shelter environments. Various organizations, including the Disaster Medical Assistance Team, the Japan Medical Association Team, and local institutions, contribute to disaster medical responses. In 2016, the Disaster Countermeasure Committee was established by the Japanese Society of Phlebology to lead VTE prevention efforts, including DVT screening, compression stocking distribution, public awareness campaigns, and promoting cardboard beds to enhance shelter conditions. In preparation for future large-scale disasters, it is vital to share evidence-based knowledge with health care professionals and the public to decrease the burden of disaster-associated VTE.

日本每年经历1000多次可感知的地震，包括2011年东日本大地震和1995年阪神-淡路大地震等重大事件。这些事件导致心血管事件的增加，特别是静脉血栓栓塞（VTE），包括肺栓塞（PE）和深静脉血栓形成（DVT）。灾害相关性静脉血栓栓塞受Virchow's三因素影响：血流动力学停滞、高凝性和内皮损伤。地震后DVT的发生率在10-30%之间，通常发生在灾后1-2周。在疏散避难所的早期干预措施，以防止静脉淤滞和高凝是至关重要的。如果不及时治疗，DVT可能发展为PE，这可能是致命的；然而，通过及时干预和改善住房环境，大多数病例是可以预防的。各种组织，包括灾害医疗援助队（DMAT）、日本医学协会小组（JMAT）和地方机构，为灾害医疗反应作出贡献。2016年，日本血液学学会成立了灾难对策委员会（DCC），领导静脉血栓栓塞预防工作，包括静脉血栓栓塞筛查、压缩袜分发、公众意识运动和推广纸板床，以改善住房条件。在准备应对未来的大规模灾害时，与医疗保健专业人员和公众分享基于证据的知识，以减轻与灾害相关的静脉血栓栓塞的负担，这一点至关重要。

{"title":"Disaster-associated venous thromboembolism countermeasures in Japan: Insights from past major earthquakes","authors":"Keisuke Kamada MD , Eri Fukaya MD, PhD , Eriko Iwata MD, PhD , Daiki Uchida MD, PhD , Makoto Mo MD, PhD , Kazuhiko Hanzawa MD, PhD , Shinsaku Ueda MD, PhD , Nobuyoshi Azuma MD, PhD","doi":"10.1016/j.jvsv.2025.102312","DOIUrl":"10.1016/j.jvsv.2025.102312","url":null,"abstract":"<div><div>Japan experiences more than 1000 perceptible earthquakes annually, including major events such as the 2011 Great East Japan Earthquake and the 1995 Great Hanshin-Awaji Earthquake. These events lead to a documented increase in cardiovascular events, particularly venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis (DVT). Disaster-associated VTE is influenced by Virchow's triad: hemodynamic stasis, hypercoagulability, and endothelial injury. The incidence of DVT after earthquakes ranges from 10% to 30%, often developing 1 to 2 weeks post disaster. Early interventions in evacuation shelters to prevent venous stasis and hypercoagulability are critical. Left untreated, DVT can progress to pulmonary embolism, which may be fatal; however, most cases are preventable through timely intervention and improved shelter environments. Various organizations, including the Disaster Medical Assistance Team, the Japan Medical Association Team, and local institutions, contribute to disaster medical responses. In 2016, the Disaster Countermeasure Committee was established by the Japanese Society of Phlebology to lead VTE prevention efforts, including DVT screening, compression stocking distribution, public awareness campaigns, and promoting cardboard beds to enhance shelter conditions. In preparation for future large-scale disasters, it is vital to share evidence-based knowledge with health care professionals and the public to decrease the burden of disaster-associated VTE.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 1","pages":"Article 102312"},"PeriodicalIF":2.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145040454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

One-year outcomes of mechanochemical ablation of incompetent saphenous veins using the Flebogrif device 使用Flebogrif®装置机械化学消融功能不全隐静脉的1年疗效

IF 2.8 2区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of vascular surgery. Venous and lymphatic disorders

Pub Date : 2026-01-01 DOI: 10.1016/j.jvsv.2025.102345

Insoo Park MD, Sujin Park MD

Objective

Flebogrif introduces a novel mechanochemical ablation technique for the treatment of incompetent saphenous veins. However, studies evaluating its efficacy as a relatively new treatment technique remain scarce. This study aimed to evaluate 1-year clinical outcomes after its application.

Methods

We conducted a retrospective analysis of 61 patients with 105 incompetent great saphenous veins who underwent treatment with Flebogrif. Primary outcomes included anatomical success rates at 1, 6, and 12 months post procedure, with secondary outcomes including adverse events, pain scores, Revised Venous Clinical Severity score, Chronic Venous Insufficiency Quality of Life Questionnaire scores, time to resumption of normal activities, and foam sclerosant dosage.

Results

The anatomical success rates were 100% at 1 month, 98.4% at 6 months, and 95.4% at 12 months. Adverse events were mild, with no severe complications such as paresthesia or deep vein thrombosis. Flebogrif facilitated the treatment of multiple veins without related adverse events, averaging a foam sclerosant dosage of 17.70 ± 6.13 mL per procedure. Both the Revised Venous Clinical Severity score and Chronic Venous Insufficiency Quality of Life Questionnaire scores demonstrated a significant reduction from baseline.

Conclusions

Flebogrif is a safe and effective technique for the treatment of multiple incompetent saphenous veins.

目的：Flebogrif®介绍了一种新的机械化学消融技术，用于治疗功能不全的隐静脉。然而，评估其作为一种相对较新的治疗技术的有效性的研究仍然很少。本研究旨在评估其应用后1年的临床结果。方法：我们对61例使用Flebogrif®治疗的大隐静脉功能不全的105例患者进行了回顾性分析。主要结果包括手术后1、6和12个月的解剖成功率，次要结果包括不良事件、疼痛评分、修订静脉临床严重程度评分（rVCSS）、慢性静脉功能不全生活质量问卷（CIVIQ14）评分、恢复正常活动的时间和泡沫硬化剂剂量。结果：1个月解剖成功率为100%，6个月为98.4%，12个月为95.4%。不良事件轻微，无严重并发症，如感觉异常或深静脉血栓形成。Flebogrif®促进了多静脉的治疗，没有相关的不良事件，每次手术平均泡沫硬化剂剂量为17.70 + 6.13 cc。rVCSS和civq14评分均显示较基线有显著降低。结论：Flebogrif®是一种安全、有效的治疗多发性无能大隐静脉的技术。

{"title":"One-year outcomes of mechanochemical ablation of incompetent saphenous veins using the Flebogrif device","authors":"Insoo Park MD, Sujin Park MD","doi":"10.1016/j.jvsv.2025.102345","DOIUrl":"10.1016/j.jvsv.2025.102345","url":null,"abstract":"<div><h3>Objective</h3><div>Flebogrif introduces a novel mechanochemical ablation technique for the treatment of incompetent saphenous veins. However, studies evaluating its efficacy as a relatively new treatment technique remain scarce. This study aimed to evaluate 1-year clinical outcomes after its application.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of 61 patients with 105 incompetent great saphenous veins who underwent treatment with Flebogrif. Primary outcomes included anatomical success rates at 1, 6, and 12 months post procedure, with secondary outcomes including adverse events, pain scores, Revised Venous Clinical Severity score, Chronic Venous Insufficiency Quality of Life Questionnaire scores, time to resumption of normal activities, and foam sclerosant dosage.</div></div><div><h3>Results</h3><div>The anatomical success rates were 100% at 1 month, 98.4% at 6 months, and 95.4% at 12 months. Adverse events were mild, with no severe complications such as paresthesia or deep vein thrombosis. Flebogrif facilitated the treatment of multiple veins without related adverse events, averaging a foam sclerosant dosage of 17.70 ± 6.13 mL per procedure. Both the Revised Venous Clinical Severity score and Chronic Venous Insufficiency Quality of Life Questionnaire scores demonstrated a significant reduction from baseline.</div></div><div><h3>Conclusions</h3><div>Flebogrif is a safe and effective technique for the treatment of multiple incompetent saphenous veins.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 1","pages":"Article 102345"},"PeriodicalIF":2.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145368367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of vascular surgery. Venous and lymphatic disorders

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀